Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
End Stage Renal Disease (ESRD): early-phase trial registry
4 of 11 indexed End Stage Renal Disease (ESRD) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 4 currently recruiting · #1,577 of 28,707 conditions by registered trial count
End Stage Renal Disease (ESRD): 11 US clinical trials tracked, 4 recruiting.
End Stage Renal Disease (ESRD) is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Venova Medical, running 2 of these trials.
Enrollment posture brief
Registry condition end-stage-renal-disease-esrd
OPEN 4 | RECR 36% | LATE 1 | EARLY 4 | RANK #1577 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (36% recruiting · 11 trials)
End Stage Renal Disease (ESRD) lists 4 open slots (36% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for End Stage Renal Disease (ESRD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
End Stage Renal Disease (ESRD) is recruiting below its size-band peers.
4 of 11 indexed trials (36.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates End Stage Renal Disease (ESRD) research.
Venova Medical accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.
-
Typical End Stage Renal Disease (ESRD) enrolment sits around 96 participants.
Median target enrolment is 96 among the 11 trials that report a genuine target (sentinel values excluded). 6 of those (54.5%) plan for fewer than 100 participants.
-
End Stage Renal Disease (ESRD) research is mostly interventional.
9 interventional and 2 observational studies make up this index (81.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis
Humacyte
NCT05908084
EndoForce Post Approval Study
Phraxis
NCT07146854
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
W.L.Gore & Associates
NCT04671771
Pivotal Study of the Velocity™ pAVF System
Venova Medical
NCT07153939
Outcome of BCF Access in Hemodialysis Patients
University of Chicago
NCT01693263
Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure
Mayo Clinic
NCT02808208
TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation
University of California, Los Angeles
NCT07287800
A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment
Eli Lilly and Company
NCT07165015
Early Feasibility Study of the Velocity™ Percutaneous Arterio-Venous Fistula System for Creating Hemodialysis Vascular Access
Venova Medical
NCT06712251
Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap
Pursuit Vascular
NCT02604264
A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD)
Epizon Pharma
NCT05285787
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on End Stage Renal Disease (ESRD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on End Stage Renal Disease (ESRD) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this End Stage Renal Disease (ESRD) page
11 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 End Stage Renal Disease (ESRD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Venova Medical sponsors the most End Stage Renal Disease (ESRD) trials on record, review their full trial history before evaluating a specific study. See Venova Medical's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This End Stage Renal Disease (ESRD) condition card totals 11 registered trials; most-linked intervention EPN-701 (Oral); top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.